Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT06378996
Other study ID # S68535
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date May 2024
Est. completion date October 2024

Study information

Verified date April 2024
Source Universitaire Ziekenhuizen KU Leuven
Contact Bert Vandenberk, MD PhD
Phone +3216338686
Email vandenberkbert@gmail.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Mitral valve prolapse (MVP) affects up to 3% of the general population and a small subset of patients is at risk for ventricular arrhythmias. This subgroup is referred to as AMVP (arrhythmic MVP) and was recently defined using the following criteria: (1) Presence of MVP), (2) Ventricular arrhythmia that is either frequent (≥5% total premature ventricular contraction (PVC) burden on Holter) or complex (non-sustained ventricular tachycardia (nsVT), ventricular tachycardia (VT), or ventricular fibrillation (VF)), and (3) The absence of any other well-defined arrhythmic substrate. Currently, diagnosis is often based on repeated 24-hour Holter monitoring. However, the ventricular arrhythmia burden varies from day-to-day and long-term rhythm monitoring has shown in other pathologies to increase the diagnostic yield with up to 200% (from 22.5% on 24h to 75.3% on 14 days). This pilot study aims to study the diagnostic yield of long-term rhythm monitoring in patients with MVP as well as the day-to-day variability of ventricular arrhythmias to facilitate power calculation for a future large-scale prospective registry.


Recruitment information / eligibility

Status Recruiting
Enrollment 60
Est. completion date October 2024
Est. primary completion date September 2024
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Patients aged 18 years or older - Mitral valve prolapse diagnosed on previous echocardiography or cardiac MRI - New York Heart association classification =3 - Willing and able to provide signed written informed consent - No contra-indication for long-term monitoring (known allergy to adhesives) Exclusion Criteria: - Prior cardiac surgery, including previous mitral valve intervention - Prior endovascular mitral valve repair (MitraClip) - Previous catheter ablation of ventricular arrhythmias - Patients not in sinus rhythm - Patients on anti-arrhythmic drugs but betablockers - Known alternative arrhythmic substrate, for example previous myocardial infarction - Known allergy to adhesives

Study Design


Related Conditions & MeSH terms


Intervention

Diagnostic Test:
14-day rhythm monitoring
Eligible patients will be monitored during 14 days using the Byteflies patch ambulatory rhythm monitor.

Locations

Country Name City State
Belgium UZ Leuven Leuven Vlaams-Brabant

Sponsors (1)

Lead Sponsor Collaborator
Universitaire Ziekenhuizen KU Leuven

Country where clinical trial is conducted

Belgium, 

Outcome

Type Measure Description Time frame Safety issue
Primary Time to arrhythmic mitral valve prolapse detection The number of days to reach the detection of arrhythmic mitral valve prolapse, defined as a PVC burden = 5%, nsVT, VT or VF 14 days
Primary Number of days with high PVC-burden =5% Number of days with a PVC-burden =5% 14 days
Primary Number of days with complex ventricular arrhythmia (nsVT, VT, or VF) Number of days with = 1 nsVT, VT or VF episode 14 days
Primary Day-to-day variation in percentage PVC burden Day-to-day variation of the absolute number of PVC burden in percentage 14 days
Secondary Association between percentage PVC burden and percentage of late gadolinium enhancement on cardiac MRI Correlation analysis of two continuous variables. The PVC burden will be calculated as the number of PVCs divided by the total number of heartbeats during the 14 days rhythm monitoring. Percentage of late gadolinium enhancement will be calculated as the ratio of the mass of myocardial tissue with late gadolinium enhancement over the total LV mass on cardiac MRI. 14 days
Secondary Association between mean number of nsVT episodes per 24hours and percentage of late gadolinium enhancement on cardiac MRI Correlation analysis of two continuous variables. The mean number of nsVT episodes will be calculated as the average of nsVT episoden per day during the 14 days rhythm monitoring. Percentage of late gadolinium enhancement will be calculated as the ratio of the mass of myocardial tissue with late gadolinium enhancement over the total LV mass on cardiac MRI 14 days
Secondary Association between percentage PVC burden and global longitudinal strain on transthoracic echocardiography Correlation analysis of two continuous variables. The PVC burden will be calculated as the number of PVCs divided by the total number of heartbeats during the 14 days rhythm monitoring. Global longitudinal strain will be measured using conventional echocardiography on the 2-chamber, 3-chamber, and 4-chamber apical view. 14 days
Secondary Association between mean number of nsVT episodes per 24hours and global longitudinal strain on transthoracic echocardiography Correlation analysis of two continuous variables. Correlation analysis of two continuous variables. The mean number of nsVT episodes will be calculated as the average of nsVT episoden per day during the 14 days rhythm monitoring. Global longitudinal strain will be measured using conventional echocardiography on the 2-chamber, 3-chamber, and 4-chamber apical view. 14 days
See also
  Status Clinical Trial Phase
Completed NCT05791032 - Sub Chronic Evaluation for ATP With an Extravascular Placed ICD Lead (STEP ICD) Study N/A
Not yet recruiting NCT06063811 - Ventricular Tachycardia Ablation in LVAD Patients
Withdrawn NCT05049720 - ExtraVascular Implantable Cardiac Defibrillator Continued Access Study N/A
Completed NCT04060680 - Extravascular ICD Pivotal Study N/A
Not yet recruiting NCT04990089 - VIVO European Observational Registry
Recruiting NCT05418036 - Safety Assessment for Sotalol Protocol in Outpatient Unit Phase 4
Recruiting NCT04264455 - Evaluation of Long-term Incidence of Ventricular Arrhythmias in Patients With Acute Myocarditis
Recruiting NCT03821051 - China Structural Ventricular Arrhythmias Registry
Recruiting NCT03880708 - China Inherited Ventricular Arrhythmias Registry
Recruiting NCT03041519 - Zero-fluoroscopic Ablation Versus Conventional Fluoroscopic Ablation for the Treatment of Ventricular Arrhythmias N/A
Completed NCT03204981 - Intramural Needle Ablation for the Treatment of Refractory Ventricular Arrhythmias N/A
Recruiting NCT04239144 - Sympathetic Denervation by Video-assisted Thoracoscopy in Control of Cardiac Arrhythmias in Patients With Chagas Disease N/A
Recruiting NCT05829993 - Development of an Artificial Intelligence Algorithm to Detect Pathological Repolarization Disorders on the ECG and the Risk of Ventricular Arrhythmias
Recruiting NCT05707637 - Bipolar Radio-frequency Ablation After Standard Unipolar Approach - Prospective Registry.
Completed NCT05357716 - Preliminary Research Evaluation for Ambulatory Leadless Electrocardiogram Recorder Trial
Recruiting NCT06158698 - CMP-MYTHiC Trial and Registry - CardioMyoPathy With MYocarditis THerapy With Colchicine Phase 3
Active, not recruiting NCT03495297 - A Randomised Trial of S-ICD Implantation With and Without Defibrillation Testing N/A
Not yet recruiting NCT06360939 - Radiotherapy vs Catheter Ablation for Ventricular Tachycardia in Structural Heart Disease N/A
Suspended NCT03502499 - Half-normal Saline in Idiopathic Left Ventricular Outflow Tract Arrhythmias Ablation N/A
Completed NCT04809701 - Non-vascular ICD Electrode Configuration Feasibility Study N/A